全文获取类型
收费全文 | 1224篇 |
免费 | 68篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 55篇 |
妇产科学 | 14篇 |
基础医学 | 146篇 |
口腔科学 | 25篇 |
临床医学 | 105篇 |
内科学 | 311篇 |
皮肤病学 | 20篇 |
神经病学 | 123篇 |
特种医学 | 105篇 |
外科学 | 87篇 |
综合类 | 4篇 |
预防医学 | 53篇 |
眼科学 | 18篇 |
药学 | 89篇 |
中国医学 | 3篇 |
肿瘤学 | 111篇 |
出版年
2022年 | 13篇 |
2021年 | 13篇 |
2020年 | 15篇 |
2019年 | 15篇 |
2018年 | 17篇 |
2017年 | 19篇 |
2016年 | 18篇 |
2015年 | 26篇 |
2014年 | 39篇 |
2013年 | 52篇 |
2012年 | 66篇 |
2011年 | 72篇 |
2010年 | 55篇 |
2009年 | 38篇 |
2008年 | 61篇 |
2007年 | 78篇 |
2006年 | 59篇 |
2005年 | 60篇 |
2004年 | 82篇 |
2003年 | 86篇 |
2002年 | 73篇 |
2001年 | 13篇 |
2000年 | 15篇 |
1999年 | 14篇 |
1998年 | 19篇 |
1997年 | 21篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1994年 | 20篇 |
1993年 | 13篇 |
1992年 | 9篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1989年 | 7篇 |
1988年 | 17篇 |
1986年 | 5篇 |
1985年 | 10篇 |
1984年 | 9篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1979年 | 6篇 |
1975年 | 7篇 |
1972年 | 7篇 |
1971年 | 7篇 |
1970年 | 5篇 |
1969年 | 6篇 |
1968年 | 6篇 |
1967年 | 5篇 |
1966年 | 8篇 |
1956年 | 5篇 |
排序方式: 共有1295条查询结果,搜索用时 15 毫秒
41.
42.
Nobuhisa MATSUMURA Takashi SHIBATA Emiko HORI Hironaga KAMIYAMA Mariko TANI Soushi OKAMOTO Michiya KUBO Yukio HORIE Shunro ENDO Satoshi KURODA 《Neurologia medico-chirurgica》2014,54(6):497-501
We describe a higher magnifying power operating microscope system to improve one method of high-quality microsurgical clipping for cerebral aneurysm in some cases. This higher magnification is achieved by a new lens design in the optical system, which makes the image of the object very clear at high magnifications (distinctiveness of 7 μm). This higher-resolution operating microscope system provides the surgeon with higher-magnified images (at the maximum of more than 30× magnifications as each working distance) in the operating field. The magnifications can be changed from low power (2.9×) to high power (62.0×) depending on the circumstances in a given procedure. We have used this operating microscope system on 11 patients with microsurgical clipping for cerebral aneurysms. Microsurgical treatment could be performed safely and precisely. All aneurysms were treated without any technical complications. We think that the use of this microscope would have potential benefits for microsurgical treatment for cerebral aneurysms because of better visualization. 相似文献
43.
Mari Akiyama Katsuhiro Kobayashi Takushi Inoue Tomoyuki Akiyama Harumi Yoshinaga 《Brain & development》2014
Purpose: Ictal fear is an uncommon condition in which fear manifests as the main feature of epileptic seizures. The literature has suggested that ictal fear is generally associated with poor seizure outcomes. We wanted to clarify the variability in seizure outcome of children with ictal fear. Subjects and methods: We identified five pediatric patients with ictal fear who were followed up on at Okayama University Hospital between January 2003 and December 2012. We retrospectively reviewed their clinical records and EEG findings. Results: The onset age of epilepsy ranged from 8 months to 9 years and 10 months. The common ictal symptoms were sudden fright, clinging to someone nearby, and subsequent impairment of consciousness, which were often accompanied by complex visual hallucinations and psychosis-like complaints. Ictal fear, in four patients, was perceived as a nonepileptic disorder by their parents. Ictal electroencephalograms (EEG) of ictal fear were obtained in all patients. Three showed frontal onset, while the other two showed centrotemporal or occipital onsets. Two patients were seizure free at last follow-up, while seizures persisted in the other three. A patient with seizure onset during infancy had a favorable outcome, which was considered to be compatible with benign partial epilepsy with affective symptoms. Conclusion: Ictal fear is not always associated with a symptomatic cause or a poor seizure outcome. It is quite important to make a correct diagnosis of ictal fear as early as possible to optimize treatment. 相似文献
44.
Tomoyuki Akiyama Katsuhiro Kobayashi Akihito Higashikage Junko Sato Harumi Yoshinaga 《Brain & development》2014
Objective: We intended to investigate the effects of age, gender, and medications on amino acid cerebrospinal fluid (CSF)/plasma ratios in children, and to determine whether amino acid transports across the blood–CSF barrier in children differ from those in adults. Patients and methods: Amino acid concentrations measured by ion-exchange high-performance liquid chromatography were used (CSF from 99 children, simultaneously collected plasma from 76 children). Influence of age, gender, and medications on the amino acid CSF concentrations and CSF/plasma ratios were analyzed by linear multiple regression. Interactions of amino acid transports were analyzed by correlation analysis of CSF/plasma ratios. Results: CSF/plasma ratios of serine, valine, histidine, and arginine were higher in younger children. The glutamate CSF/plasma ratio was higher in older children. Serine, alanine, threonine, valine, and histidine CSF/plasma ratios were lower in females. Glutamine, methionine, tyrosine, and phenylalanine CSF/plasma ratios were elevated with valproate therapy. Serine, threonine, valine, leucine, and tyrosine CSF/plasma ratios were lower with clobazam therapy. The asparagine CSF/plasma ratio was elevated with pyridoxal phosphate therapy. Transports of most essential neutral amino acids interacted with each other, as did neutral amino acids with low molecular weights. Cationic amino acids interacted with each other and some essential neutral amino acids. Acidic amino acids had no interactions with other amino acids. Conclusions: Age, gender, and anti-epileptic drugs affect amino acid CSF/plasma ratios in children. Transport interactions between amino acids in children showed no remarkable difference from those of adults and generally followed the substrate specificities of multiple amino acid transport systems. 相似文献
45.
Jong-Hwan Park Masashi Miyashita Masaki Takahashi Noriaki Kawanishi Harumi Hayashida Hyun-Shik Kim Katsuhiko Suzuki Yoshio Nakamura 《Journal of Sports Science and Medicine》2014,13(3):624-631
Although numerous sources of evidence show that regular physical activity is beneficial to health, most individuals do not engage in a sufficient amount of physical activity to meet the guidelines set out by expert panels. In addition, the minimum amount of physical activity associated with reduced cardiovascular disease risk markers is not clear in older adults. The purpose of this study was to determine the effects of a 12-week walking program involving an exercise volume below the current minimum physical activity recommendation on cardiovascular disease risk markers in older adults. The participants were recruited from the following two groups separately: a walking group (n = 14) and a control group (n = 14). In the walking group, participants walked 30 to 60 minutes per session on 2 days per week for 12 weeks (average walking time, 49.4 ± 8.8 min/session). Plasma oxidised low-density lipoprotein concentrations tended to be lower than baseline values in the walking group after 12 weeks (paired t-test, p = 0.127). The ratio of oxidised low-density lipoprotein to high-density lipoprotein cholesterol was significantly lower than the baseline ratio in the walking group after 12 weeks (paired t-test, p = 0.035). Resting systolic blood pressure and diastolic blood pressure were significantly lower than baseline values in the walking group after 12 weeks (paired t-tests, p = 0.002, p < 0.0005, respectively). Our findings demonstrate that a 12-week walking program comprising a low volume of physical activity confers a benefit to cardiovascular-related health in older adults.
Key Points
- It is important to consider baseline physical activity levels when evaluating physical activity program.
- Being physically active is important to reduce the potential risk marker of cardiovascular disease in older adults.
- These data imply that a small volume of 12-week walking program confers a benefit to cardiovascular-related health in older adults.
46.
Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm 下载免费PDF全文
Peggy P. Li Akira Nakanishi Sean W. Clark Harumi Kasamatsu 《Proceedings of the National Academy of Sciences of the United States of America》2002,99(3):1353-1358
Pentamer formation by Vp1, the major capsid protein of simian virus 40, requires an interdigitation of structural elements from the Vp1 monomers [Liddington, R. C., Yan, Y., Moulai, J., Sahli, R., Benjamin, T. L. & Harrison, S. C. (1991) Nature (London) 354, 278-284]. Our analyses reveal that disulfide-linked Vp1 homooligomers are present in the simian virus 40-infected cytoplasm and that they are derived from a 41-kDa monomeric intermediate containing an intrachain disulfide bond(s). The 41-kDa species, emerging within 5 min of pulse labeling with [(35)S]methionine, is converted into a 45-kDa, disulfide-free Vp1 monomer and disulfide-bonded dimers through pentamers. The covalent oligomer formation is blocked in the presence of a sulfhydryl-modifying reagent. We propose that there are two stages in this Vp1 disulfide bonding. First, the newly synthesized Vp1 monomers acquire intrachain bonds as they fold and begin to interact. Next, these bonds are replaced with intermolecular bonds as the monomers assemble into pentamers. This sequential appearance of transitory disulfide bonds is consistent with a role for sulfhydryl-disulfide redox reactions in the coordinate folding of Vp1 chains into pentamers. The cytoplasmic Vp1 does not colocalize with marker proteins of the endoplasmic reticulum. This paper demonstrates in vivo disulfide formations and exchanges coupled to the folding and oligomerization of a mammalian protein in the cytoplasm, outside the secretory pathway. Such disulfide dynamics may be a general phenomenon for other cysteine-bearing mammalian proteins that fold in the cytoplasm. 相似文献
47.
Nerome Y Imanaka H Nonaka Y Tsuru Y Maeno N Takezaki T Mori H Akaike H Kubota T Kawano Y Takei S 《Modern rheumatology / the Japan Rheumatism Association》2008,18(2):189-192
We report a 27-year-old case of juvenile idiopathic arthritis (JIA) having been stopped infliximab during pregnancy. She was
safely treated by infliximab therapy with premedications for preventing infusin reactions after her delivery, and then improved
in the same manner as when she had been treated with infliximab therapy before pregnancy. As a result, it remains unclear
whether or not we can use infliximab to control disease activities during pregnancy. In addition, it is also important to
clarify whether or not premedications should be used when resuming infliximab treatment in such patients after pregnancy.
These problems still remain controversial. More definitive data are needed in order to allow rheumatologists to better select
the optimal TNF-alpha inhibitor therapy when treating pregnant JIA patients. 相似文献
48.
49.
50.
Tomoro Hishiki Hiroshi Horie Yasuyuki Higashimoto Katsumi Yotsumoto Shugo Komatsu Yuri Okimoto Harumi Kakuda Yuichi Taneyama Takeshi Saito Keita Terui Tetsuya Mitsunaga Mitsuyuki Nakata Hidemasa Ochiai Moeko Hino Kumiko Ando Hideo Yoshida Jun Iwai 《Pediatric surgery international》2014,30(9):919-926